Skip to main
Auroa Peptides Copper-peptide, aesthetic-blend and melanocortin research for skin remodeling, hair, pigmentation and anti-aging.

SKIN & AESTHETICS / COLOPHON

About This Review Bench

A citation-grounded review bench for the skin and aesthetics peptide literature. Nothing sold here, no clinic, no medical advice.

The subject

Auroa Peptides is a review bench for the published research on two entries in the Skin & Aesthetics space: GHK-Cu (copper tripeptide-1) and the GLOW multi-peptide research blend. The aim is to make a scattered and frequently overstated literature legible — to tell a reader, in measured language and with citations, what each compound was actually studied for, in which models, and how far that evidence reaches.

The organizing question sits at the center of skin research: how does the body rebuild and hold its matrix — the collagen and elastin scaffolding that gives skin structure, elasticity, and tone? GHK-Cu is the most thoroughly studied peptide answer to it. GLOW is a newer combination that builds on GHK-Cu by adding vascular and cell-migration signals, at the cost of a more tangled regulatory picture and the absence of any blend-level human trial. Read together they give a fuller view than either alone. Each entry has its own page, and a comparison page sets them side by side.

How the bench works

Three rules govern the bench.

Everything rests on the peer-reviewed literature. Every research claim carries a numbered citation — PubMed-indexed articles and reviews, with DOIs and PubMed or PMC links — collected on the references page. A finding from a review, rather than a primary study, is cited as such.

Evidence is reported at its actual strength. Doses and results appear in the species and model where they were studied — for example, stimulation began at 10 picomolar in human fibroblast cultures — never scaled to people or offered as a recommendation. Where evidence is preclinical, drawn from a cosmetic trial rather than a therapeutic one, or based on a parent molecule rather than the marketed blend, the page says so. That candor about limits is the core of the bench.

The two entries cross-reference. Because GHK-Cu is one of GLOW's three constituents, the pages share citations and link together, so a reader can follow the matrix-synthesis mechanism from one entry into the blend context.

Where the bench stops

Auroa Peptides is not a store, not a clinic, and not a source of medical or cosmetic advice. Nothing is sold, supplied, sourced, or brokered here — no peptide, research chemical, or cosmetic product — and no affiliate or referral tie connects it to any vendor or clinic. No clinicians staff these pages, no conditions are diagnosed, and nothing is prescribed; no dose, schedule, or route is named for anyone.

The entries range from a legal cosmetic ingredient (topical GHK-Cu) to an unapproved multi-peptide blend with WADA-prohibited constituents (GLOW). A reader drawn to any finding in the underlying research should consult a licensed clinician in their own jurisdiction, working from regulated options fit to their situation. What the site offers is a calm, accurate reading of the published literature — and nothing it isn't.